{"url_path":"/sec/tpst/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1544227/0001193125-26-257684-index.html","accession_number":"0001193125-26-257684","cik":"0001544227","ticker":"TPST","issuer_name":"Tempest Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1544227/0001193125-26-257684-index.html","primary_entity_key":"0001544227","primary_entity_name":"Tempest Therapeutics, Inc."},"word_count":82,"has_tables":true,"body_markdown":"Item 9.01.\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nNumber\n  \nDescription\n\n99.1\n  \n[Press Release, dated June 4, 2026, furnished herewith.](d91703dex991.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nTEMPEST THERAPEUTICS, INC.\n\nDate: June 4, 2026\n \n\n \nBy:\n \n\n/s/ Matthew Angel\n\n \n\n \nName:\n \nMatthew Angel\n\n \n\n \nTitle:\n \nPresident and Chief Executive Officer"}